Lumen News

Lumen News image

Lumen News image

Lumen Seeks Partner Take Its C. Into Phase III

Lumen Seeks Partner Take Its C. Into Phase III

October 22, 2026

Seattle biotech Lumen reports Phase 2 win in C. diff

Seattle biotech Lumen reports Phase 2 win in C. diff

October 22, 2026

Lumen’s LMN-201 Shows Positive RePreve Results in C. difficile

Lumen’s LMN-201 Shows Positive RePreve Results in C. difficile

October 22, 2026

LMN-201 Reduces C difficile Recurrence

LMN-201 Reduces C difficile Recurrence

October 22, 2026

Lumen Bioscience lands up to $7M from Department of War for antiviral trial

Lumen Bioscience lands up to $7M from Department of War for antiviral trial

September 5, 2026

Pentagon-backed Lumen is ready to drastically slash antibody manufacturing costs

Pentagon-backed Lumen is ready to drastically slash antibody manufacturing costs

November 20, 2025

Lumen Bioscience raises $30M Series C extension

Lumen Bioscience raises $30M Series C extension

October 8, 2025

Revolutionizing the Production of Biologics with Algae

Revolutionizing the Production of Biologics with Algae

June 4, 2025

Past Wilkes Prize winners accelerate audacious climate solutions

Past Wilkes Prize winners accelerate audacious climate solutions

May 30, 2025